Quince Therapeutics, Inc.

QNCX·NasdaqGS
Compare
31.73+2.37 (+8.07%)today
At close: Oct 9, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close29.36
Open30.50
Day range29.8437.00
52-week range15.10910.00
Off day high−14.24%
Off 52-week high−96.51%
Volume138.74K
Avg. volume (3M)30.98K
Market cap32.27M
EPS (TTM)-214.01
Forward P/E-6.78
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding1.02M
Short interest—
Earnings dateAug 14, 2026 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
QNCX ATHE VYGR QNTM ABVC GANX
Market cap 32.27M 53.35M 139.87M 18.13M 26.16M 68.52M
P/E (TTM) — — — — — —
Forward P/E -6.8 -3.1 -1.8 -0.4 -2.2 -2.3
Price/book -0.9 1.8 0.9 2.7 2.4 6.0
Dividend yield — — — — — —
1-year change −91.65% −38.05% −54.42% −82.36% −67.11% −23.04%
Today +8.07% −6.98% −7.35% −4.08% −2.02% −4.27%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All QNCX news ›
TradingView·Positive

Total debt of Quince Therapeutics, Inc. – NASDAQ:IRLA

Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular…

TradingView·Positive

Asset turnover of Quince Therapeutics, Inc. – NASDAQ:IRLA

Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular…

TradingView·Positive

Enterprise value of Quince Therapeutics, Inc. – NASDAQ:IRLA

Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular…

TradingView·Positive

Taxes of Quince Therapeutics, Inc. – NASDAQ:IRLA

Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular…

From articles in the 4Search news index.

In the news

16mentions in 30 days
16with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.